{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:02:18Z","timestamp":1775898138238,"version":"3.50.1"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background And Objectives:<\/jats:title>\n                  <jats:p>Disseminated herpes simplex virus (HSV) infection is the most fulminant type of neonatal HSV infection and has the highest mortality. Early diagnosis and treatment are essential for patient survival. We describe the clinical presentation, laboratory characteristics, and outcomes of neonates with disseminated HSV infection at our institution.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>A retrospective review of electronic medical records from 2006 to 2013 was performed. Only neonates with disseminated HSV infection, confirmed by using polymerase chain reaction or viral culture results, were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Twenty-two cases were identified; the age range was 1 to 14 days. The majority of patients did not have a maternal history of HSV or a history of maternal fever at delivery. Eleven of the patients were delivered by cesarean delivery, and 3 of these patients did not have prolonged rupture of membranes. Neonatal fever, the most common historical characteristic, was present in only one-half of the patients. Pneumonia and respiratory distress were present in one-half of the patients. Serum aspartate aminotransferase and alanine aminotransferase levels were elevated in most, but not all, patients. The blood HSV polymerase chain reaction was positive in all patients tested. Of the 22 study patients, 16 survived and 6 died. The majority of the patients who died had respiratory disease and a delay in the initiation of acyclovir therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Disseminated HSV infection in neonates can be challenging to diagnose and is associated with high mortality. Clinicians must strongly consider this diagnosis, test the blood for HSV polymerase chain reaction, and initiate early treatment in the appropriate clinical scenarios.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2013-0086","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T11:15:24Z","timestamp":1398942924000},"page":"167-171","source":"Crossref","is-referenced-by-count":32,"title":["Clinical and Laboratory Characteristics of Disseminated Herpes Simplex Virus Infection in Neonates"],"prefix":"10.1542","volume":"4","author":[{"given":"David","family":"Kotzbauer","sequence":"first","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Frank","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Shore","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"issue":"1","key":"2021120908204992800_B1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-0134","article-title":"Incidence of neonatal herpes simplex virus infections in the United States","volume":"127","author":"Flagg","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"2021120908204992800_B2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/GCO.0b013e3283294840","article-title":"Herpes simplex virus: incidence of neonatal herpes simplex virus, maternal screening, management during pregnancy, and HIV","volume":"21","author":"Roberts","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"5","key":"2021120908204992800_B3","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.ajog.2006.10.911","article-title":"The incidence of neonatal herpes infection","volume":"196","author":"Mahnert","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021120908204992800_B4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.108.2.223","article-title":"National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Natural history of neonatal herpes simplex virus infections in the acyclovir era","volume":"108","author":"Kimberlin","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"2021120908204992800_B5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.semperi.2007.01.003","article-title":"Herpes simplex virus infections of the newborn","volume":"31","author":"Kimberlin","year":"2007","journal-title":"Semin Perinatol"},{"issue":"7","key":"2021120908204992800_B6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/INF.0b013e31820e3398","article-title":"Herpes simplex virus infection in young infants during 2 decades of empiric acyclovir therapy","volume":"30","author":"Long","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"2021120908204992800_B7","volume-title":"Nelson Textbook of Pediatrics","author":"Kliegman","year":"2011","edition":"19th ed."},{"key":"2021120908204992800_B8","first-page":"708","volume-title":"Nelson Textbook of Pediatrics","author":"Kliegman","year":"2011","edition":"19th ed."},{"issue":"2","key":"2021120908204992800_B9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant","volume":"289","author":"Brown","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"2021120908204992800_B10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00007435-198907000-00007","article-title":"National surveillance for neonatal herpes simplex virus infections","volume":"16","author":"Stone","year":"1989","journal-title":"Sex Transm Dis"},{"key":"2021120908204992800_B11","first-page":"398","volume-title":"Red Book: 2012 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2012","edition":"29th ed"},{"issue":"6","key":"2021120908204992800_B12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1542\/peds.2011-0177","article-title":"Delayed acyclovir therapy and death among neonates with herpes simplex virus infection","volume":"128","author":"Shah","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"2021120908204992800_B13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1542\/peds.108.2.230","article-title":"National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections","volume":"108","author":"Kimberlin","year":"2001","journal-title":"Pediatrics"},{"issue":"7","key":"2021120908204992800_B14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199102143240703","article-title":"Infectious Diseases Collaborative Antiviral Study Group. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection","volume":"324","author":"Whitley","year":"1991","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120908204992800_B15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpeds.2008.04.071","article-title":"In defense of empiric acyclovir therapy in certain neonates","volume":"153","author":"Long","year":"2008","journal-title":"J Pediatr"},{"issue":"2","key":"2021120908204992800_B16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpeds.2008.04.027","article-title":"When should you initiate acyclovir therapy in a neonate?","volume":"153","author":"Kimberlin","year":"2008","journal-title":"J Pediatr"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/4\/3\/167\/839030\/hpeds_2013-0086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/4\/3\/167\/839030\/hpeds_2013-0086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T02:39:59Z","timestamp":1639103999000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/4\/3\/167\/73317\/Clinical-and-Laboratory-Characteristics-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,5,1]]},"published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2013-0086","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}